Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Drug Name | ABM-1310 |
| Trade Name | |
| Synonyms | ABM1310|ABM 1310 |
| Drug Descriptions |
ABM-1310 inhibits BRAF V600, including BRAF V600E, potentially leading to inhibition of tumor growth (Cancer Res (2020) 80 (16_Supplement): 4038). |
| DrugClasses | BRAF Inhibitor 26 |
| CAS Registry Number | NA |
| NCIT ID | C170951 |
| Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
|---|---|---|---|
| ABM-1310 | ABM-1310 | 2 | 1 |
| ABM-1310 + Binimetinib | ABM-1310 Binimetinib | 1 | 0 |
| ABM-1310 + Cetuximab | ABM-1310 Cetuximab | 1 | 0 |
| ABM-1310 + Cobimetinib | ABM-1310 Cobimetinib | 1 | 1 |